Last reviewed · How we verify
Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine (M-BOOST-FR)
This study is to evaluate the long-term immunogenicity of a boost dose of MVA-BN vaccine
Details
| Lead sponsor | Assistance Publique - Hôpitaux de Paris |
|---|---|
| Status | RECRUITING |
| Enrolment | 90 |
| Start date | 2025-05-07 |
| Completion | 2027-11 |
Conditions
- Monkeypox
Primary outcomes
- Immunogenicity a of a booster dose of MVA-BN vaccine — 12 months
To evaluate the immunogenicity at 12 months of a booster dose of MVA-BN vaccine administered subcutaneously in HIV PrEP users.
Countries
France